Ashima Bhatia
Impact in
- Molecular Medicine top 5%
- Antibiotic Resistance in Bacteria
-
- Antibiotic Use and Resistance
Papers in
-
- Antibiotic Resistance in Bacteria 6
-
- Antibiotics Pharmacokinetics and Efficacy 8
- Co-authors
- Ravindra YeoleKeith A. RodvoldMark H. GotfriedSunita SaxenaChintamani ChintamaniJP SinghMahesh Kumar MittalAnju Bansal
- Journals
- Antimicrobial Agents and Chemotherapy (6 papers)AAPS PharmSciTech (1 paper)Clinical and Translational Science (1 paper)Drug Design Development and Therapy (1 paper)Open Forum Infectious Diseases (1 paper)
- Partner nations
- IndiaUnited StatesNepal
In The Last Decade
Ashima Bhatia
21 papers receiving 348 citations
Peers
Comparison fields: 5 of 78
- Molecular Medicine 107
- Applied Microbiology and Biotechnology 34
- Pharmacology 116
- Rehabilitation 35
- Clinical Biochemistry 28
Countries citing papers authored by Ashima Bhatia
This map shows the geographic impact of Ashima Bhatia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ashima Bhatia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ashima Bhatia more than expected).
Fields of papers citing papers by Ashima Bhatia
This network shows the impact of papers produced by Ashima Bhatia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ashima Bhatia. The network helps show where Ashima Bhatia may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Ashima Bhatia, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 2 | |
| 2 | 2024 | 7 | |
| 3 | 2024 | 1 | |
| 4 | 2023 | 5 | |
| 5 | 2022 | 4 | |
| 6 | 2022 | 2 | |
| 7 | 2019 | 51 | |
| 8 | 2019 | 8 | |
| 9 | 2018 | 12 | |
| 10 | 2018 | 29 | |
| 11 | 2018 | 33 | |
| 12 | 2018 | 12 | |
| 13 | 2017 | 16 | |
| 14 | 2017 | 29 | |
| 15 | 2016 | 1 | |
| 16 | 2005 | 7 | |
| 17 | 2005 | 63 | |
| 18 | 2004 | 64 | |
| 19 | Efficacy & tolerability of ondansetron compared to metoclopramide in dose dependent cisplatin-induced delayed emesis. | 2004 | 2 |
| 20 | Comparison of ondansetron with metoclopramide in prevention of acute emesis associated with low dose & high dose cisplatin chemotherapy. | 2003 | 4 |
About Ashima Bhatia
Ashima Bhatia is a scholar working on Molecular Medicine, Pharmacology, Pharmacy, Urology and Epidemiology, having authored 22 papers that have together received 362 indexed citations. Recurring topics across this work include Antibiotics Pharmacokinetics and Efficacy (8 papers), Pneumonia and Respiratory Infections (7 papers), Antibiotic Resistance in Bacteria (6 papers), Nausea and vomiting management (2 papers), Crystallization and Solubility Studies (2 papers), Periodontal Regeneration and Treatments (2 papers), Gastroesophageal reflux and treatments (1 paper) and SARS-CoV-2 and COVID-19 Research (1 paper). The work is most often cited by research in Molecular Medicine (107 citations), Applied Microbiology and Biotechnology (34 citations), Pharmacology (116 citations), Rehabilitation (35 citations) and Clinical Biochemistry (28 citations). Ashima Bhatia has collaborated with scholars based in India, United States and Nepal. Frequent co-authors include Ravindra Yeole, Keith A. Rodvold, Mark H. Gotfried, Sunita Saxena, Chintamani Chintamani, JP Singh, Mahesh Kumar Mittal, Anju Bansal, H. David Friedland and Mahesh Patel. Their work appears in journals such as Antimicrobial Agents and Chemotherapy, AAPS PharmSciTech, Clinical and Translational Science, Drug Design Development and Therapy and Open Forum Infectious Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.